Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct 3:10:ELIXIR-1129.
doi: 10.12688/f1000research.74502.2. eCollection 2021.

ELIXIR and Toxicology: a community in development

Affiliations

ELIXIR and Toxicology: a community in development

Marvin Martens et al. F1000Res. .

Abstract

Toxicology has been an active research field for many decades, with academic, industrial and government involvement. Modern omics and computational approaches are changing the field, from merely disease-specific observational models into target-specific predictive models. Traditionally, toxicology has strong links with other fields such as biology, chemistry, pharmacology and medicine. With the rise of synthetic and new engineered materials, alongside ongoing prioritisation needs in chemical risk assessment for existing chemicals, early predictive evaluations are becoming of utmost importance to both scientific and regulatory purposes. ELIXIR is an intergovernmental organisation that brings together life science resources from across Europe. To coordinate the linkage of various life science efforts around modern predictive toxicology, the establishment of a new ELIXIR Community is seen as instrumental. In the past few years, joint efforts, building on incidental overlap, have been piloted in the context of ELIXIR. For example, the EU-ToxRisk, diXa, HeCaToS, transQST, and the nanotoxicology community have worked with the ELIXIR TeSS, Bioschemas, and Compute Platforms and activities. In 2018, a core group of interested parties wrote a proposal, outlining a sketch of what this new ELIXIR Toxicology Community would look like. A recent workshop (held September 30th to October 1st, 2020) extended this into an ELIXIR Toxicology roadmap and a shortlist of limited investment-high gain collaborations to give body to this new community. This Whitepaper outlines the results of these efforts and defines our vision of the ELIXIR Toxicology Community and how it complements other ELIXIR activities.

Keywords: ELIXIR; FAIR; Toxicology; interoperability.

PubMed Disclaimer

Conflict of interest statement

No competing interests were disclosed.

Similar articles

  • A community proposal to integrate structural bioinformatics activities in ELIXIR (3D-Bioinfo Community).
    Orengo C, Velankar S, Wodak S, Zoete V, Bonvin AMJJ, Elofsson A, Feenstra KA, Gerloff DL, Hamelryck T, Hancock JM, Helmer-Citterich M, Hospital A, Orozco M, Perrakis A, Rarey M, Soares C, Sussman JL, Thornton JM, Tuffery P, Tusnady G, Wierenga R, Salminen T, Schneider B. Orengo C, et al. F1000Res. 2020 Apr 22;9:ELIXIR-278. doi: 10.12688/f1000research.20559.1. eCollection 2020. F1000Res. 2020. PMID: 32566135 Free PMC article.
  • The future of metabolomics in ELIXIR.
    van Rijswijk M, Beirnaert C, Caron C, Cascante M, Dominguez V, Dunn WB, Ebbels TMD, Giacomoni F, Gonzalez-Beltran A, Hankemeier T, Haug K, Izquierdo-Garcia JL, Jimenez RC, Jourdan F, Kale N, Klapa MI, Kohlbacher O, Koort K, Kultima K, Le Corguillé G, Moreno P, Moschonas NK, Neumann S, O'Donovan C, Reczko M, Rocca-Serra P, Rosato A, Salek RM, Sansone SA, Satagopam V, Schober D, Shimmo R, Spicer RA, Spjuth O, Thévenot EA, Viant MR, Weber RJM, Willighagen EL, Zanetti G, Steinbeck C. van Rijswijk M, et al. F1000Res. 2017 Sep 6;6:ELIXIR-1649. doi: 10.12688/f1000research.12342.2. eCollection 2017. F1000Res. 2017. PMID: 29043062 Free PMC article.
  • Systems Biology in ELIXIR: modelling in the spotlight.
    Martins Dos Santos V, Anton M, Szomolay B, Ostaszewski M, Arts I, Benfeitas R, Dominguez Del Angel V, Domínguez-Romero E, Ferk P, Fey D, Goble C, Golebiewski M, Gruden K, Heil KF, Hermjakob H, Kahlem P, Klapa MI, Koehorst J, Kolodkin A, Kutmon M, Leskošek B, Moretti S, Müller W, Pagni M, Rezen T, Rocha M, Rozman D, Šafránek D, T Scott W, Sheriff RSM, Suarez Diez M, Van Steen K, Westerhoff HV, Wittig U, Wolstencroft K, Zupanic A, Evelo CT, Hancock JM. Martins Dos Santos V, et al. F1000Res. 2022 Nov 7;11:ELIXIR-1265. doi: 10.12688/f1000research.126734.2. eCollection 2022. F1000Res. 2022. PMID: 36742342 Free PMC article.
  • Information extraction in the life sciences: perspectives for medicinal chemistry, pharmacology and toxicology.
    Zimmermann M, Fluck J, Thi le TB, Kolárik C, Kumpf K, Hofmann M. Zimmermann M, et al. Curr Top Med Chem. 2005;5(8):785-96. doi: 10.2174/1568026054637692. Curr Top Med Chem. 2005. PMID: 16101418 Review.
  • The Minderoo-Monaco Commission on Plastics and Human Health.
    Landrigan PJ, Raps H, Cropper M, Bald C, Brunner M, Canonizado EM, Charles D, Chiles TC, Donohue MJ, Enck J, Fenichel P, Fleming LE, Ferrier-Pages C, Fordham R, Gozt A, Griffin C, Hahn ME, Haryanto B, Hixson R, Ianelli H, James BD, Kumar P, Laborde A, Law KL, Martin K, Mu J, Mulders Y, Mustapha A, Niu J, Pahl S, Park Y, Pedrotti ML, Pitt JA, Ruchirawat M, Seewoo BJ, Spring M, Stegeman JJ, Suk W, Symeonides C, Takada H, Thompson RC, Vicini A, Wang Z, Whitman E, Wirth D, Wolff M, Yousuf AK, Dunlop S. Landrigan PJ, et al. Ann Glob Health. 2023 Mar 21;89(1):23. doi: 10.5334/aogh.4056. eCollection 2023. Ann Glob Health. 2023. PMID: 36969097 Free PMC article. Review.

Cited by

  • Comprehensive mapping of the AOP-Wiki database: identifying biological and disease gaps.
    Jaylet T, Coustillet T, Smith NM, Viviani B, Lindeman B, Vergauwen L, Myhre O, Yarar N, Gostner JM, Monfort-Lanzas P, Jornod F, Holbech H, Coumoul X, Sarigiannis DA, Antczak P, Bal-Price A, Fritsche E, Kuchovska E, Stratidakis AK, Barouki R, Kim MJ, Taboureau O, Wojewodzic MW, Knapen D, Audouze K. Jaylet T, et al. Front Toxicol. 2024 Mar 8;6:1285768. doi: 10.3389/ftox.2024.1285768. eCollection 2024. Front Toxicol. 2024. PMID: 38523647 Free PMC article.

References

    1. Crosswell LC, Thornton JM: ELIXIR: a distributed infrastructure for European biological data. Trends Biotechnol. may 2012;30(5):241–242. 10.1016/j.tibtech.2012.02.002 - DOI - PubMed
    1. Kortenkamp A: Low dose mixture effects of endocrine disrupters and their implications for regulatory thresholds in chemical risk assessment. Curr. Opin. Pharmacol. 2014;19:105–111. 10.1016/j.coph.2014.08.006 - DOI - PubMed
    1. Escher BI, Stapleton HM, Schymanski EL: Tracking complex mixtures of chemicals in our changing environment. Science. 2020;367(6476):388–392. 10.1126/science.aay6636 - DOI - PMC - PubMed
    1. Tropsha A: Best practices for QSAR model development, validation, and exploitation. Molecular Informatics. 2010;29(6-7):476–488. 10.1002/minf.201000061 - DOI - PubMed
    1. Patlewicz G, Ball N, Booth ED, et al. : Use of category approaches, read-across and (q)sar: General considerations. Regul. Toxicol. Pharmacol. 2013;67(1):1–12. 10.1016/j.yrtph.2013.06.002 - DOI - PubMed